Association between P2Y12 inhibitor reloading and in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome already on chronic P2Y12 receptor inhibitors therapy in China: findings from the CCC-ACS (improving care for cardiovascular disease in China-acute coronary syndrome) project

被引:67
|
作者
Wang, Yintang [1 ]
Geng, Yu [1 ]
Zhang, Ou [1 ]
Xu, Qin [2 ,3 ]
Xue, Yajun [1 ]
Zhou, Boda [1 ]
Zhang, Ping [1 ]
Li, Aihua
Li, Bao
Xu, Biao
Han, Guangshu
Li, Bin
Liu, Bin
Wang, Bin
Fu, Bing
Yu, Bo
Yang, Bosong
Luo, Caidong
Wang, Changqian
Liu, Changyong
Liang, Chuanliang
Gao, Chuanyu
Lai, Chunlin
Wang, Chuntong
Zhang, Chunyan
Wu, Chunyang
Zhang, Congliang
Bin, Cui
Huang, Lan
Peng, Daoquan
Xu, Dawen
Wu, Di
Zhu, Dongmei
Chai, Dongsheng
Li, Dongyan
Tang, Fakuan
Xiao, Jun
Zhao, Fang
Huang, Fangfang
Meng, Fanju
Li, Fengwei
Gan, Fudong
Xu, Gang
Sang, Gengsheng
Ma, Genshan
Zhang, Guixia
Tao, Guizhou
Li, Guo
Chen, Guoduo
Xin, Guoqin
机构
[1] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Sch Clin Med, Dept Cardiol, 168 Litang Rd, Beijing 102218, Peoples R China
[2] Capital Med Univ, Beijing Tiantan Hosp, China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China
关键词
P2Y12 receptor inhibitors; Non-ST-segment elevation acute coronary syndrome; Loading dose; Outcome; Therapy; DUAL ANTIPLATELET THERAPY; MYOCARDIAL-INFARCTION; EUROPEAN-SOCIETY; ARTERY-DISEASE; FOCUSED UPDATE; 2017; ESC; CLOPIDOGREL; ASPIRIN; ANGIOPLASTY; GUIDELINES;
D O I
10.1186/s40001-023-01025-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background The association between P2Y12 receptor inhibitors reloading and in-hospital outcomes in non-ST-segment elevation acute coronary syndrome (NSTEACS) patients who were on chronic P2Y12 receptor inhibitors therapy remained underdetermined.Methods The Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS project) is a national registry active from November 2014 to December 2019. 4790 NSTEACS patients on chronic P2Y12 receptor inhibitors therapy were included. Cox proportional hazard models, Kaplan-Meier curves, and subgroup analyses were conducted.Results The NSTEACS patients who received reloading of P2Y12 receptor inhibitors were younger and had fewer comorbid conditions. The reloading group had a lower risk of major adverse cardiac events (MACE) (0.51% vs. 1.43%, P = 0.007), and all-cause death (0.36% vs. 0.99%, P = 0.028), the risks of myocardial infarction and major bleeding were not significantly different between patients with and without reloading. In survival analysis, a lower cumulative risk of MACE could be identified (Log-rank test, P = 0.007) in reloading group. In the unadjusted Cox model, reloading P2Y12 receptor inhibitors was associated with a decreased risk of MACE [HR, 0.35; 95% CI 0.16-0.78; (P = 0.010)] and all-cause death [HR, 0.37; 95% CI 0.14-0.94; (P = 0.036)]. Reloading of P2Y12 receptor inhibitors was associated with a decreased risk of MACE in most of the subgroups.Conclusions In NSTEACS patients already taking P2Y12 receptor inhibitors, we observed a decreased risk of in-hospital MACEs and all-cause mortality and did not observe an increased risk of major bleeding, with reloading. The differential profile in the two groups might influence this association and further studies are warranted.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Pretreatment with a P2Y12 receptor inhibitor and delay to coronary artery bypass surgery in patients with non-ST segment elevation acute coronary syndrome
    Gomes, Daniel A.
    Rocha, Bruno M.
    Ferreira, Jorge
    Paiva, Mariana S.
    Santos, Rita R. E. I. S.
    Santos, Marina R.
    Cunha, Goncalo
    Goncalves, Pedro D. E. ARAuJO
    Fevereiro, Susana
    Trabulo, Marisa
    Aguiar, Carlos
    Sousa-uva, Miguel
    Neves, Jose
    Mendes, Miguel
    MINERVA CARDIOLOGY AND ANGIOLOGY, 2023, 71 (05) : 582 - 589
  • [22] P2Y12 Inhibitor Adherence Patterns in Patients with Acute Coronary Syndrome
    Ozaki, Aya
    Ko, Dennis T.
    Chong, Alice
    Fang, Jiming
    Austin, Peter
    Sud, Maneesh
    Jackevicius, Cynthia A.
    CIRCULATION, 2021, 144
  • [23] P2Y12 Inhibitor Pretreatment in Non-ST-Segment Elevation Acute Coronary Syndrome The NCDR Chest Pain-MI Registry
    Ueyama, Hiroki A.
    Kennedy, Kevin F.
    Rymer, Jennifer A.
    Sandhu, Alexander T.
    Kuno, Toshiki
    Masoudi, Frederick A.
    Spertus, John A.
    Kohsaka, Shun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2025, 85 (04) : 322 - 334
  • [24] P2Y12 INHIBITORS IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME: INSIGHTS FROM A SYSTEMATIC REVIEW AND META ANALYSIS OF RANDOMIZED TRIALS
    Fujisaki, Tomohiro
    Briasoulis, Alexandros
    Takagi, Hisato
    Kuno, Toshiki
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S153 - S153
  • [25] In-Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC-ACS (Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome) Project
    Zhao, Guanqi
    Zhou, Mengge
    Ma, Changsheng
    Huo, Yong
    Smith, Sidney C., Jr.
    Fonarow, Gregg C.
    Ge, Junbo
    Han, Yaling
    Liu, Jing
    Hao, Yongchen
    Liu, Jun
    Wang, Xiao
    Taubert, Kathryn A.
    Morgan, Louise
    Zhao, Dong
    Nie, Shaoping
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (07):
  • [26] Admission fasting plasma glucose is associated with in-hospital outcomes in patients with acute coronary syndrome and diabetes: findings from the improving Care for Cardiovascular Disease in China - Acute Coronary Syndrome (CCC-ACS) project
    Nan Ye
    Lijiao Yang
    Guoqin Wang
    Weijing Bian
    Fengbo Xu
    Changsheng Ma
    Dong Zhao
    Jing Liu
    Yongchen Hao
    Jun Liu
    Na Yang
    Hong Cheng
    BMC Cardiovascular Disorders, 20
  • [27] A risk score to predict in-hospital mortality in patients with acute coronary syndrome at early medical contact: results from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) Project
    Ran, Peng
    Yang, Jun-Qing
    Li, Jie
    Li, Guang
    Wang, Yan
    Qiu, Jia
    Zhong, Qi
    Wang, Yu
    Wei, Xue-Biao
    Huang, Jie-Leng
    Siu, Chung-Wah
    Zhou, Ying-Ling
    Zhao, Dong
    Yu, Dan-Qing
    Chen, Ji-Yan
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (02)
  • [28] Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project
    Mengge Zhou
    Jing Liu
    Yongchen Hao
    Jun Liu
    Yong Huo
    Sidney C. Smith
    Junbo Ge
    Changsheng Ma
    Yaling Han
    Gregg C. Fonarow
    Kathryn A. Taubert
    Louise Morgan
    Na Yang
    Yueyan Xing
    Dong Zhao
    Cardiovascular Diabetology, 17
  • [29] Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project
    Zhou, Mengge
    Liu, Jing
    Hao, Yongchen
    Liu, Jun
    Huo, Yong
    Smith, Sidney C., Jr.
    Ge, Junbo
    Ma, Changsheng
    Han, Yaling
    Fonarow, Gregg C.
    Taubert, Kathryn A.
    Morgan, Louise
    Yang, Na
    Xing, Yueyan
    Zhao, Dong
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [30] Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)
    Eliaz, R.
    Mengesha, B.
    Ovdat, T.
    Iakobishvili, Z.
    Hasdai, D.
    Kheifets, M.
    Klempfner, R.
    Beigel, R.
    Kalmanovich, E.
    Alcalai, R.
    Levi, A.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1414 - 1414